Literature DB >> 6384259

Relationship among peripheral glucose uptake, oxygen consumption, and glucose turnover in postabsorptive man.

R A Jackson, J B Hamling, P M Blix, J D Nabarro.   

Abstract

To assess the importance of glucose uptake by muscle in determining total glucose utilization in the basal state, forearm glucose uptake (FGU), reflecting mainly skeletal muscle metabolism, and glucose turnover using [3-3H]glucose were studied simultaneously in 17 postabsorptive normal men. Mean +/- SE glucose disappearance was 2.36 +/- 0.14 mg/kg X min, amounting to 170 +/- 9 mg/min, while FGU was 0.049 +/- 0.009 mg/100 ml forearm X min. When the latter was calculated in terms of skeletal muscle in the body as a whole, muscle glucose utilization was found to be 24.7 +/- 4.5 mg/min, comprising only 13.5 +/- 1.9% of the total glucose disappearance. Forearm oxygen consumption was 6.6 +/- 0.5 mumol/100 ml forearm X min, of which only 26 +/- 5% could be accounted for by concurrent glucose uptake. These results suggest that in the basal state, glucose uptake by skeletal muscle accounts for 1) only a small percentage of total glucose disappearance and 2) only a minor proportion of peripheral oxygen consumption, which may be more dependent on lipid oxidation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384259     DOI: 10.1210/jcem-59-5-857

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes.

Authors:  Dora Il'yasova; Ivan Spasojevic; Karel Base; Haoyue Zhang; Frances Wang; Sarah P Young; David S Millington; Ralph B D'Agostino; Lynne E Wagenknecht
Journal:  Diabetes Care       Date:  2011-11-18       Impact factor: 19.112

2.  Urinary F2-isoprostanes and metabolic markers of fat oxidation.

Authors:  Dora Il'yasova; Lynne E Wagenknecht; Ivan Spasojevic; Steven Watkins; Donald Bowden; Frances Wang; Ralph B D'Agostino
Journal:  Oxid Med Cell Longev       Date:  2015-02-23       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.